MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/156802611798281348

Медицинская библиотека · Current topics in medicinal chemistry · 2011

The immunoproteasome: an emerging therapeutic target.

Lee Wooin, Kim Kyung Bo

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The proteasome, a large multisubunit protease complex, has been extensively investigated over the years, greatly enhancing our understanding of critical roles that the proteasome plays in cells. The FDA approval of bortezomib for the treatment of multiple myeloma and mantle cell lymphoma has validated the proteasome as an anticancer target. However, the undesirable toxicities of these agents limit their broad utility. The immunoproteasome, an alternative form of the constitutive proteasome, has recently been explored as a therapeutic target. While the immunoproteasome, normally expressed in cells of hematopoietic origin, has been shown to be associated with various types of cancer and inflammatory diseases, its multifaceted function is not fully understood due to the lack of appropriate molecular probes. In this review, recent advances in the immunoproteasome field are covered, including potential implications in disease states. In particular, recent developments in immunoproteasome-specific inhibitors are emphasized.

Для цитирования: Lee Wooin, Kim Kyung Bo. The immunoproteasome: an emerging therapeutic target.. Current topics in medicinal chemistry. 2011. DOI: 10.2174/156802611798281348.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.